UnitedHealth Group Incorporated (DE) ($UNH) Stock Forecast: Down 5.0% Today

What is UnitedHealth Group Incorporated (DE)?

UnitedHealth Group (UNH) is a diversified healthcare company that offers health insurance services, operating through two business platforms UnitedHealthcare and Optum. The stock had a bearish movement today amidst regulatory and legal challenges, trading below key moving averages.

Why is UnitedHealth Group Incorporated (DE) going down?

UNH stock is down 5.0% on Mar 27, 2026 16:46

• UNH stock declined by 3.14% due to persistent bearish momentum driven by regulatory and legal challenges, leading to a single-digit profit decline projection for the upcoming quarter.
• Analysts expect a profit decrease year-over-year for UNH's next earnings report, attributing underperformance to challenges like higher medical costs and declining Medicare Advantage enrollment.
• The bearish trend in UNH stock is further confirmed by technical indicators, signaling a high probability of continued downside unless the stock breaks decisively above $281.
• The positive movements in CVS Health Corporation (CVS), Boston Scientific Corp (BSX), and iRhythm Technologies did not directly impact UNH's bearish movement, as each company has its own unique growth drivers and catalysts influencing their stock performance.

UNH Price Chart

UNH Technical Analysis

UNH News

-3.14% for UnitedHealth stock as persistent bearish momentum drives fresh lows

UnitedHealth Group (UNH) stock declined 3.14% to $259.64, trading below key moving averages and indicating persistent bearish momentum due to regulatory and legal challenges. Analysts project a single-digit profit decline and $110.08 billion in sales for the upcoming quarter. Technical indicators confirm the bearish trend, with a high probability of further downside in the short term unless the stock decisively breaks above $281.

https://tradersunion.com/news/financial-news/show/1811451-unitedhealth-declines-3-14percent-to-usd259-64/

Fort Washington Investment Advisors Inc. OH Boosts Holdings in CVS Health Corporation $CVS

Fort Washington Investment Advisors Inc. OH increased its stake in CVS Health Corporation (NYSE:CVS) by 2.9% during the fourth quarter, now owning 725,189 shares valued at $57.55 million. Several other institutional investors also adjusted their positions in CVS Health, which recently reported strong quarterly earnings and declared a dividend. The company is trading with a market capitalization of $90.42 billion and analysts generally have a "Moderate Buy" rating with an average price target of $95.05.

https://www.marketbeat.com/instant-alerts/filing-fort-washington-investment-advisors-inc-oh-boosts-holdings-in-cvs-health-corporation-cvs-2026-03-27/

Here's What to Expect From UnitedHealth's Next Earnings Report

UnitedHealth Group (UNH) is scheduled to release its Q1 2026 earnings, with analysts expecting a profit of $6.62 per share, an 8.1% decrease year-over-year. The company's shares have significantly underperformed the S&P 500 and the healthcare sector ETF over the past year, partly due to challenges like higher medical costs and declining Medicare Advantage enrollment. Despite these issues, Wall Street maintains a "Moderate Buy" rating, projecting a potential upside of 33.9% from current levels.

https://www.barchart.com/story/news/995743/here-s-what-to-expect-from-unitedhealth-s-next-earnings-report

Boston Scientific Corp Stock (BSX) Moved Up by 3.66% on Mar 26: Key Drivers Unveiled

Boston Scientific (BSX) stock climbed 3.66% on March 26, driven by positive analyst sentiment, anticipation of WATCHMAN device clinical trial results, and the strategic acquisition of Penumbra for $14.5 billion. Analysts maintain "Strong Buy" ratings with price targets up to $120, reflecting confidence despite an ongoing class-action lawsuit. The upcoming CHAMPION-AF data presentation and investor event are key immediate catalysts.

https://www.tradingkey.com/news/Market-Movers/261724781-market-movers-bsx-20260326

iRhythm Technologies Stock: Analyzing Growth Drivers and Investor Opportunities in Cardiac Monitorin

iRhythm Technologies is a leader in wearable cardiac monitoring through its Zio platform, demonstrating strong revenue growth driven by increasing demand for remote diagnostics. North American investors should consider the company's international expansion and reimbursement dynamics as key catalysts for future performance. The company's innovative Zio XT patch offers continuous ECG monitoring, utilizing AI algorithms to detect arrhythmias, and is well-positioned in a rapidly growing market for digital health and remote patient monitoring.

https://www.ad-hoc-news.de/boerse/ueberblick/irhythm-technologies-stock-analyzing-growth-drivers-and-investor/68996451

Trending Today

Stitch Fix Inc. ($SFIX) Stock Forecast: Down 5.1% Today

Avis Budget Group Inc. ($CAR) Stock Forecast: Down 5.1% Today

Boston Scientific Corporation ($BSX) Stock Forecast: Down 5.1% Today

Micron Technology Inc. ($MU) Stock Forecast: Down 5.1% Today

AFLAC Incorporated ($AFL) Stock Forecast: Up 1.8% Today

SolarEdge Technologies, Inc. ($SEDG) Stock Forecast: Down 5.2% Today

Beyond Meat Inc. ($BYND) Stock Forecast: Down 5.8% Today

CleanSpark Inc ($CLSK) Stock Forecast: Down 6.3% Today

United Therapeutics Corporation ($UTHR) Stock Forecast: Up 0.5% Today

MKS Instruments Inc. ($MKSI) Stock Forecast: Down 5.8% Today

UnitedHealth Group Incorporated (DE) Price History

05.00.2026 - UNH Stock was up 1.0%

• UnitedHealth Group's strong bullish movement today can be attributed to positive developments in the healthcare and insurance sectors.
• The increase in price target for Humana, a competitor in the healthcare industry, indicates overall optimism and potential growth in the sector, which could have positively impacted UNH's stock.
• UnitedHealth Group retaining its lead position in net premiums written showcases its strong market position and stability, likely contributing to investor confidence and buying interest in the stock.
• Despite a reduction in stake by City Holding Co., the overall institutional investment in the company and its strong financial performance, including surpassing earnings estimates and announcing a dividend, could have outweighed this sell-off, driving the stock price higher.

24.01.2026 - UNH Stock was down 5.0%

• UNH stock dipped 2.64% today, underperforming broader market indices like the S&P 500, Dow, and Nasdaq.
• Analysts anticipate a decline in EPS for the upcoming release, signaling potential concerns about the company's financial performance.
• The bearish movement could be attributed to general market volatility, concerns about healthcare regulatory risks, and potentially lower-than-expected financial results for the company.

24.01.2026 - UNH Stock was down 5.2%

• Today's bearish movement in UNH stock could be explained by:
• Concerns related to regulatory challenges and policy uncertainties impacting the healthcare sector, leading to a broader decline in healthcare stocks.
• DaVita Inc.'s strong earnings report and potential as a competitor in the healthcare space possibly diverting investor attention away from UNH.
• Weaker-than-expected earnings from Humana Inc. and the changing regulatory landscape in the healthcare industry potentially influencing negative market sentiment towards UNH and other healthcare stocks.
• The focus on affordability and value-based care in the healthcare industry, as emphasized by Humana's President, possibly raising worries about profit margins for companies like UNH amidst rising cost pressures.

02.00.2026 - UNH Stock was up 2.6%

• SteelPeak Wealth LLC increased its stake in UNH, showcasing confidence in the company's future and contributing to positive market sentiment.
• Although Allspring Global Investments Holdings LLC reduced its holdings in UNH, other institutional investors have displayed interest in the company, reflecting overall market confidence in the stock.
• UNH is making operational changes post external audits to enhance efficiency and tackle issues impacting profit forecasts, a move that could be positively viewed by investors.
• Concerns surrounding Medicare Advantage risks and reimbursement pressures affecting Humana's stock may have indirectly favored UNH as investors pursue more stable investment options in the healthcare industry.

27.00.2026 - UNH Stock was down 17.8%

• UNH stock showed bearish movement, potentially due to profit-taking following a recent uptrend.
• Positive earnings from Sysco Corp. and the all-time high of CH Robinson Worldwide Inc could have shifted investor focus away from UNH.
• The mixed performance of Dow Jones and Nasdaq futures, with tech earnings in focus, might have influenced market sentiment, impacting UNH negatively.
• The appointment of a new Chief Legal Officer at Central Garden & Pet may have generated positive sentiment for the company, diverting attention from UNH.

27.00.2026 - UNH Stock was down 17.7%

• The bearish movement in UnitedHealth Group (UNH) stock today can be attributed to the following factors:
• Despite the overall market showing mixed movements, specific healthcare stocks like UnitedHealth Group may have faced pressure due to concerns about potential regulatory changes or shifts in healthcare policies.
• The underperformance of UnitedHealth Group could also be influenced by company-specific factors such as lower-than-expected earnings, increased competition in the healthcare sector, or changes in reimbursement rates.
• Investors might be rotating out of healthcare stocks like UnitedHealth Group and into other sectors like technology, as indicated by the positive movements in tech stocks like Cloudflare Inc. and EquipmentShare.com Inc. in pre-market trading.
• The market may be reacting to news about other companies like Sysco Corp. beating earnings expectations, leading investors to reallocate their investments away from healthcare and into sectors with stronger financial performance.

27.00.2026 - UNH Stock was down 19.2%

• The stock of UnitedHealth faced significant downward movement today due to lower-than-expected reimbursement rates proposed by the Trump administration for 2027 in the Medicare Advantage sector.
• UnitedHealth's Q4 report did not meet the expectations of analysts, contributing to the decline in its stock price.
• Morningstar highlighted the continued regulatory hurdles faced by UnitedHealth in its Medicare Advantage and pharmacy benefit management divisions, adding to market uncertainty.
• In the broader sector, concerns were exacerbated by Centene's notable stock decrease following the announcement of unanticipated flat payment increases for Medicare Advantage in 2027 by federal regulators.

27.00.2026 - UNH Stock was down 19.5%

• UnitedHealth's decline in the market is linked to its intention to decrease Medicare Advantage benefits following reduced reimbursement rates proposed for 2027.
• The stock's drop was also influenced by the negative response to UnitedHealth's earnings report, which did not meet Street expectations.
• The health insurance sector as a whole, including companies like Elevance Health and CVS Health, is grappling with issues such as stagnant Medicare Advantage rates and regulatory investigations, resulting in a downturn for the sector.
• Despite UnitedHealth's 2026 profit forecast aligning with projections, ongoing regulatory obstacles in its Medicare Advantage and pharmacy benefit management divisions are causing uncertainty among investors, potentially delaying a significant profit improvement.

27.00.2026 - UNH Stock was down 19.6%

• UnitedHealth Group's stock experienced a significant bearish movement of 19% following its Q4 2025 earnings report, where GAAP earnings saw a drastic year-over-year decline.
• The market reacted negatively to the news of UnitedHealth's plummeting GAAP earnings, which raised concerns about the company's financial performance and outlook.
• The downward pressure on UNH stock was further intensified by the broader market sentiment towards health insurance companies, as evidenced by the decline in Elevance Health (ELV) stock following UnitedHealth's earnings report.
• Despite the current sell-off, UnitedHealth Group remains optimistic about a potential rebound in GAAP earnings for 2026, which could present a buying opportunity for investors looking at the long-term growth prospects of the company.

18.10.2025 - UNH Stock was down 5.0%

• The bearish movement in UNH stock could be attributed to the bearish approach adopted by deep-pocketed investors towards the company, as highlighted in the options market analysis.
• The decrease in short interest as a percent of float may have also contributed to the downward pressure on UNH stock, indicating reduced market optimism towards the company.
• Despite positive news surrounding other companies in the healthcare sector, the specific bearish sentiment towards UnitedHealth Group seems to have weighed down its stock performance today.

27.02.2026 - UNH Stock was down 5.0%

• UNH stock declined by 3.14% due to persistent bearish momentum driven by regulatory and legal challenges, leading to a single-digit profit decline projection for the upcoming quarter.
• Analysts expect a profit decrease year-over-year for UNH's next earnings report, attributing underperformance to challenges like higher medical costs and declining Medicare Advantage enrollment.
• The bearish trend in UNH stock is further confirmed by technical indicators, signaling a high probability of continued downside unless the stock breaks decisively above $281.
• The positive movements in CVS Health Corporation (CVS), Boston Scientific Corp (BSX), and iRhythm Technologies did not directly impact UNH's bearish movement, as each company has its own unique growth drivers and catalysts influencing their stock performance.

12.10.2025 - UNH Stock was up 5.4%

• UNH saw a 9.6% decrease in its stock value post Q3 earnings beat, as concerns related to escalating medical expenses and margin pressure tested investor resilience.
• Options trading on UNH reflected a mix of positive and negative sentiments from affluent investors, contributing to heightened stock volatility.
• Notably, sizable investors endorsing bullish positions in UNH potentially influenced the robust market upsurge observed.
• The interplay between conflicting options trends and investor reactions to financial performance likely influenced UNH's market performance.